LLY•benzinga•May 16, 2024 at 10:49 AM

Eli Lilly's QWINT-2 And QWINT-4 Phase 3 Trials Of Once-weekly Insulin Efsitora In Type 2 Diabetes Patients Using Insulin For First Time And Require Multiple Daily Injections, Efsitora Showed Non-Inferior A1C Reduction Vs. Most Commonly Used Daily Insulin

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 16, 2024 by benzinga